Pfizer inflammatory bowel disease drug wins European Commission approval

(Reuters) – Pfizer on Monday said the European Commission has approved the company’s drug to treat patients with an inflammatory bowel disease called ulcerative colitis.

The approval for the drug Velsipity follows backing from the European Medicines Agency’s panel of experts in December.

(Reporting by Leroy Leo in Bengaluru; editing by Jason Neely)